Levi Strauss & Co.
NYSE:LEVIApparel - Manufacturers
-$0.42 today
- Market cap
- $9.22B
- Beta
- 1.33
- P/E (TTM)
- 14.7
- EPS (TTM)
- $1.59
- Dividend yield
- 2.39%
Volume 2.35M
Average 2.82M
LEVI Total Liabilities
Everything the company owes to creditors and other parties.
Levi Strauss & Co.NYSE: LEVI
Total Liabilities · Q3 FY2026 · quarter ended Aug 2026
Total liabilities broadly unchanged from a year ago
Total liabilities stood at $4.51B at the end of Q3 FY2026, up 0.5% from a year earlier and up 3.7% from the prior quarter. Over 3 fiscal years it compounded at +3.4% a year.
Context
- Total liabilities amounted to 65.1% of total assets at the end of Q3 FY2026, down 2.4 pp from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +0.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 4.57B USD
- Year-over-year change
- +3.8%
- 4-year CAGR
- +1.9%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-30 | 4.57B | +3.8% |
| FY2024 | 2024-11-30 | 4.41B | +9.9% |
| FY2023 | 2023-11-30 | 4.01B | -3.1% |
| FY2022 | 2022-11-30 | 4.13B | -2.4% |
| FY2021 | 2021-11-30 | 4.23B | — |
Total Liabilities vs competitors
How LEVI compares with its peers on the latest reported figures
- LEVI's Aug 2026 total liabilities of $4.51B is the 6th highest of the 11 companies compared; the peer median is $3.73B.
- Its year-over-year change of +0.5% is the 5th highest of 11, against a peer median of -1.0%.
- Total liabilities amounts to 65.1% of total assets for LEVI, versus a peer median of 63.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Aug 2026 | $8.91B | +2.2% | -1.2% | 69.3% | |
| Jun 2026 | $7.7B | -13.1% | -12.4% | 81.4% | |
| Jun 2026 | $6.71B | +159.5% | +62.8% | 66.8% | |
| Aug 2026 | $6.62B | -2.0% | +0.7% | 58.0% | |
| Jun 2026 | $4.94B | -5.7% | -6.2% | 64.5% | |
| Aug 2026 | $4.51B | +0.5% | +3.4% | 65.1% | |
| Aug 2026 | $2.52B | -0.1% | +8.9% | 58.8% | |
| Jul 2026 | $2.27B | +6.5% | +5.1% | 44.3% | |
| Aug 2026 | $2.23B | +11.6% | +1.9% | 61.9% | |
| Jul 2026 | $2.05B | -7.8% | +14.9% | 76.8% | |
| Jun 2026 | $1.2B | -3.3% | +3.0% | 42.8% | |
| Peer median (excluding LEVI) | $3.73B | -1.0% | +2.4% | 63.2% | |
Competitors are the stored peer set for LEVI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Nov 2021 | FY2022 Nov 2022 | FY2023 Nov 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 810.27M | 429.6M | 398.8M | 690M | 757.9M |
| Short-term Investments | 91.55M | 70.6M | 0 | 0 | 90.9M |
| Net Receivables | 707.63M | 697M | 752.7M | 710M | 774.7M |
| Inventory | 897.95M | 1.42B | 1.29B | 1.13B | 1.24B |
| Other Current Assets | 202.51M | 213.9M | 196M | 319.8M | 292.5M |
| Total Current Assets | 2.71B | 2.83B | 2.64B | 2.85B | 3.15B |
| Property, Plant & Equipment (Net) | 1.61B | 1.59B | 1.71B | 1.75B | 1.83B |
| Goodwill | 386.88M | 365.7M | 303.7M | 277.6M | 280.6M |
| Intangible Assets | 291.33M | 286.7M | 267.6M | 196.6M | 194.4M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 573.11M | 625M | 729.5M | 798.5M | 830.1M |
| Other Non-current Assets | 332.58M | 339.7M | 400.6M | 498.8M | 560M |
| Total Non-current Assets | 3.19B | 3.21B | 3.42B | 3.52B | 3.7B |
| Total Assets | 5.9B | 6.04B | 6.05B | 6.38B | 6.85B |
| Account Payables | 524.8M | 657.2M | 567.9M | 663.4M | 597.6M |
| Short-term Debt | 5.9M | 11.7M | 12.5M | 5.5M | 0 |
| Tax Payables | 14.48M | 66.3M | 105.1M | 109.3M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 13.22M | 764M | 704.9M | 267.4M | 13.4M |
| Total Current Liabilities | 1.87B | 1.98B | 1.79B | 2.01B | 2.03B |
| Long-term Debt | 1.02B | 984.5M | 1.01B | 994M | 1.04B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 374.61M | 308.9M | 297.2M | 440M | 492.9M |
| Total Non-current Liabilities | 2.36B | 2.15B | 2.22B | 2.39B | 2.54B |
| Total Liabilities | 4.23B | 4.13B | 4.01B | 4.41B | 4.57B |
| Common Stock | 400K | 400K | 400K | 400K | 400K |
| Retained Earnings | 1.47B | 1.7B | 1.75B | 1.67B | 1.9B |
| Accumulated OCI | (394.39M) | (421.7M) | (390.9M) | (434.5M) | (407.2M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.67B | 1.9B | 2.05B | 1.97B | 2.28B |
| Total Debt | 2.24B | 2.09B | 2.18B | 2.21B | 2.31B |
| Net Debt | 1.43B | 1.66B | 1.78B | 1.52B | 1.55B |
Levi Strauss & Co.
NYSE:LEVI
Intrinsic Alpha fair value
Locked
Current Price
$24.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.